Availability of anticancer biosimilars in 40 countries-MedSci.cn

Availability of anticancer biosimilars in 40 countries

Huang, HY; Wu, DW; Ma, F; Liu, ZL; Shi, JF; Chen, X; Wang, SH; Fang, H; Bai, Y; Yu, Y; Fang, Y; Sun, C; Fan, Q; Wu, Y; Fan, RH; Zhou, CY; He, BX; Dai, M; Li, N; Xu, BH; Sun, Y; He, J

Li, N (corresponding author), Chinese Acad Med Sci, Canc Hosp, Natl Clin Res Ctr Canc, Natl Canc Ctr,Clin Trials Ctr, Beijing 100021, Peoples R China.